vs
Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $111.5M, roughly 1.7× AVIAT NETWORKS, INC.). AVIAT NETWORKS, INC. runs the higher net margin — 5.1% vs 0.9%, a 4.2% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -5.7%). AVIAT NETWORKS, INC. produced more free cash flow last quarter ($22.5M vs $16.0M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 0.3%).
Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
AVNW vs FOLD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $111.5M | $185.2M |
| Net Profit | $5.7M | $1.7M |
| Gross Margin | 32.4% | 85.7% |
| Operating Margin | 6.5% | 8.6% |
| Net Margin | 5.1% | 0.9% |
| Revenue YoY | -5.7% | 23.7% |
| Net Profit YoY | 27.2% | -88.5% |
| EPS (diluted) | $0.44 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $111.5M | $185.2M | ||
| Q3 25 | $107.3M | $169.1M | ||
| Q2 25 | $115.3M | $154.7M | ||
| Q1 25 | $112.6M | $125.2M | ||
| Q4 24 | $118.2M | $149.7M | ||
| Q3 24 | $88.4M | $141.5M | ||
| Q2 24 | $116.7M | $126.7M | ||
| Q1 24 | $110.8M | $110.4M |
| Q4 25 | $5.7M | $1.7M | ||
| Q3 25 | $162.0K | $17.3M | ||
| Q2 25 | $5.2M | $-24.4M | ||
| Q1 25 | $3.5M | $-21.7M | ||
| Q4 24 | $4.5M | $14.7M | ||
| Q3 24 | $-11.9M | $-6.7M | ||
| Q2 24 | $1.5M | $-15.7M | ||
| Q1 24 | $3.9M | $-48.4M |
| Q4 25 | 32.4% | 85.7% | ||
| Q3 25 | 33.2% | 88.5% | ||
| Q2 25 | 34.2% | 90.2% | ||
| Q1 25 | 34.9% | 90.7% | ||
| Q4 24 | 34.6% | 90.1% | ||
| Q3 24 | 22.4% | 90.6% | ||
| Q2 24 | 35.3% | 91.1% | ||
| Q1 24 | 32.5% | 87.7% |
| Q4 25 | 6.5% | 8.6% | ||
| Q3 25 | 4.8% | 20.3% | ||
| Q2 25 | 7.7% | -6.1% | ||
| Q1 25 | 8.3% | -6.3% | ||
| Q4 24 | 6.7% | 10.7% | ||
| Q3 24 | -17.6% | 15.3% | ||
| Q2 24 | 4.7% | 11.8% | ||
| Q1 24 | 5.1% | -25.1% |
| Q4 25 | 5.1% | 0.9% | ||
| Q3 25 | 0.2% | 10.2% | ||
| Q2 25 | 4.5% | -15.8% | ||
| Q1 25 | 3.1% | -17.3% | ||
| Q4 24 | 3.8% | 9.8% | ||
| Q3 24 | -13.4% | -4.8% | ||
| Q2 24 | 1.3% | -12.4% | ||
| Q1 24 | 3.5% | -43.9% |
| Q4 25 | $0.44 | $0.00 | ||
| Q3 25 | $0.01 | $0.06 | ||
| Q2 25 | $0.42 | $-0.08 | ||
| Q1 25 | $0.27 | $-0.07 | ||
| Q4 24 | $0.35 | $0.05 | ||
| Q3 24 | $-0.94 | $-0.02 | ||
| Q2 24 | $0.11 | $-0.05 | ||
| Q1 24 | $0.30 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.5M | $293.5M |
| Total DebtLower is stronger | $105.4M | $392.7M |
| Stockholders' EquityBook value | $271.6M | $274.2M |
| Total Assets | $659.4M | $949.9M |
| Debt / EquityLower = less leverage | 0.39× | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $86.5M | $293.5M | ||
| Q3 25 | $64.8M | $263.8M | ||
| Q2 25 | $59.7M | $231.0M | ||
| Q1 25 | $49.4M | $250.6M | ||
| Q4 24 | $52.6M | $249.9M | ||
| Q3 24 | $51.0M | $249.8M | ||
| Q2 24 | $64.6M | $260.1M | ||
| Q1 24 | $59.2M | $239.6M |
| Q4 25 | $105.4M | $392.7M | ||
| Q3 25 | $106.5M | $392.0M | ||
| Q2 25 | $87.6M | $391.3M | ||
| Q1 25 | $73.9M | $390.7M | ||
| Q4 24 | $74.9M | $390.1M | ||
| Q3 24 | $83.4M | $389.5M | ||
| Q2 24 | $48.4M | $388.9M | ||
| Q1 24 | $48.9M | $388.4M |
| Q4 25 | $271.6M | $274.2M | ||
| Q3 25 | $263.6M | $230.4M | ||
| Q2 25 | $263.2M | $204.3M | ||
| Q1 25 | $256.1M | $193.6M | ||
| Q4 24 | $249.6M | $194.0M | ||
| Q3 24 | $247.1M | $178.8M | ||
| Q2 24 | $255.9M | $132.5M | ||
| Q1 24 | $256.0M | $130.7M |
| Q4 25 | $659.4M | $949.9M | ||
| Q3 25 | $643.3M | $868.8M | ||
| Q2 25 | $633.3M | $815.3M | ||
| Q1 25 | $628.3M | $789.8M | ||
| Q4 24 | $594.1M | $785.0M | ||
| Q3 24 | $590.9M | $786.6M | ||
| Q2 24 | $535.2M | $749.5M | ||
| Q1 24 | $490.3M | $721.8M |
| Q4 25 | 0.39× | 1.43× | ||
| Q3 25 | 0.40× | 1.70× | ||
| Q2 25 | 0.33× | 1.92× | ||
| Q1 25 | 0.29× | 2.02× | ||
| Q4 24 | 0.30× | 2.01× | ||
| Q3 24 | 0.34× | 2.18× | ||
| Q2 24 | 0.19× | 2.93× | ||
| Q1 24 | 0.19× | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.9M | $16.3M |
| Free Cash FlowOCF − Capex | $22.5M | $16.0M |
| FCF MarginFCF / Revenue | 20.2% | 8.6% |
| Capex IntensityCapex / Revenue | 1.3% | 0.2% |
| Cash ConversionOCF / Net Profit | 4.18× | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $16.1M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $23.9M | $16.3M | ||
| Q3 25 | $-11.7M | $35.7M | ||
| Q2 25 | $10.5M | $-26.5M | ||
| Q1 25 | $1.6M | $7.8M | ||
| Q4 24 | $20.8M | $-3.9M | ||
| Q3 24 | $-27.2M | $-23.0M | ||
| Q2 24 | $8.3M | $22.7M | ||
| Q1 24 | $15.3M | $-29.7M |
| Q4 25 | $22.5M | $16.0M | ||
| Q3 25 | $-13.5M | $35.3M | ||
| Q2 25 | $8.2M | $-28.9M | ||
| Q1 25 | $-1.2M | $7.5M | ||
| Q4 24 | $18.3M | $-4.2M | ||
| Q3 24 | $-32.6M | $-23.3M | ||
| Q2 24 | $7.5M | $21.6M | ||
| Q1 24 | $14.8M | $-31.5M |
| Q4 25 | 20.2% | 8.6% | ||
| Q3 25 | -12.6% | 20.9% | ||
| Q2 25 | 7.1% | -18.7% | ||
| Q1 25 | -1.0% | 6.0% | ||
| Q4 24 | 15.5% | -2.8% | ||
| Q3 24 | -36.8% | -16.5% | ||
| Q2 24 | 6.4% | 17.0% | ||
| Q1 24 | 13.4% | -28.5% |
| Q4 25 | 1.3% | 0.2% | ||
| Q3 25 | 1.6% | 0.2% | ||
| Q2 25 | 2.0% | 1.6% | ||
| Q1 25 | 2.5% | 0.2% | ||
| Q4 24 | 2.1% | 0.2% | ||
| Q3 24 | 6.1% | 0.3% | ||
| Q2 24 | 0.7% | 0.9% | ||
| Q1 24 | 0.4% | 1.6% |
| Q4 25 | 4.18× | 9.62× | ||
| Q3 25 | -72.48× | 2.06× | ||
| Q2 25 | 2.02× | — | ||
| Q1 25 | 0.46× | — | ||
| Q4 24 | 4.62× | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.37× | — | ||
| Q1 24 | 3.96× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNW
| Products | $81.2M | 73% |
| Services | $30.3M | 27% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
